This is a Validated Antibody Database (VAD) review about human CD69, based on 217 published articles (read how Labome selects the articles), using CD69 antibody in all methods. It is aimed to help Labome visitors find the most suited CD69 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD69 synonym: AIM; BL-AC/P26; CLEC2C; EA1; GP32/28; MLR-3

BioLegend
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 4c
BioLegend CD69 antibody (Biolegend, 310922) was used in flow cytometry on human samples (fig 4c). Cell Rep Med (2021) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; 1:200; loading ...; fig 6f
BioLegend CD69 antibody (BioLegend, 310912) was used in flow cytometry on human samples at 1:200 (fig 6f). Nat Commun (2021) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; 1:100; fig 4i
BioLegend CD69 antibody (Biolegend, 310930) was used in flow cytometry on human samples at 1:100 (fig 4i). Nat Med (2021) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 5a
BioLegend CD69 antibody (Biolegend, 310906) was used in flow cytometry on human samples (fig 5a). J Clin Invest (2021) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 5
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 5). Arthritis Res Ther (2021) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig 3b). Acta Neuropathol (2021) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD69 antibody (BioLegend, 310944) was used in flow cytometry on human samples (fig 3a). Immunity (2021) ncbi
mouse monoclonal (FN50)
  • flow cytometry; African green monkey; fig 4e
BioLegend CD69 antibody (Biolegend, 310931) was used in flow cytometry on African green monkey samples (fig 4e). Cell (2021) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 3b
BioLegend CD69 antibody (Biolegend, 310910) was used in flow cytometry on human samples (fig 3b). elife (2020) ncbi
mouse monoclonal (FN50)
  • other; mouse
BioLegend CD69 antibody (BioLegend, FN50) was used in other on mouse samples . Nat Commun (2020) ncbi
mouse monoclonal (FN50)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend CD69 antibody (BioLegend, 310924) was used in flow cytometry on mouse samples (fig 2a). Cell (2020) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; 1:100; loading ...; fig 2i
BioLegend CD69 antibody (BioLegend, 310926) was used in flow cytometry on human samples at 1:100 (fig 2i). elife (2020) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig s3b
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig s3b). Aging (Albany NY) (2020) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; 1:200; loading ...; fig 7c
BioLegend CD69 antibody (BioLegend, 310921) was used in flow cytometry on human samples at 1:200 (fig 7c). elife (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 3c). Nature (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD69 antibody (BioLegend, 310904) was used in flow cytometry on human samples (fig s1b). J Exp Med (2020) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3s2b
BioLegend CD69 antibody (Biolegend, 310905) was used in flow cytometry on human samples (fig 3s2b). elife (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD69 antibody (Biolegend, 310914) was used in flow cytometry on human samples (fig 1b). Cell Mol Gastroenterol Hepatol (2020) ncbi
mouse monoclonal (FN50)
  • other; human; loading ...; fig 4a
BioLegend CD69 antibody (BioLegend, 310947) was used in other on human samples (fig 4a). Cell (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 5c
BioLegend CD69 antibody (BioLegend, 310914) was used in flow cytometry on human samples (fig 5c). Cell (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 4a). Sci Rep (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig s2
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig s2). JCI Insight (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 5c
BioLegend CD69 antibody (Biolegend, 310906) was used in flow cytometry on human samples (fig 5c). Front Immunol (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 7a
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig 7a). Front Pharmacol (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; mouse; loading ...; fig 5e
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on mouse samples (fig 5e). Front Immunol (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 4c
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 4c). PLoS Pathog (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 5a, 5b
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 5a, 5b). Front Immunol (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD69 antibody (BioLegend, 310932) was used in flow cytometry on human samples (fig 1b). JCI Insight (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD69 antibody (BioLegend, 310910) was used in flow cytometry on human samples (fig 3a). Biol Reprod (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 1b). J Clin Invest (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 7a
BioLegend CD69 antibody (BioLegend, 310906) was used in flow cytometry on human samples (fig 7a). Cell (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 2f
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig 2f). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 4b). J Clin Invest (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 3a
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 3a). Sci Rep (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...
In order to investigate the effectiveness of a neoantigen vaccine against melanoma, BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (FN50)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend CD69 antibody (BioLegend, FN50) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 6c
In order to study the role of leukocyte antigen F in and antigen presentation and immune response, BioLegend CD69 antibody (BioLegend, 310930) was used in flow cytometry on human samples (fig 6c). Immunity (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1a
In order to detail MAIT cell responses to various microorganisms and cytokines, BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 1a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD69 antibody (BioLegend, 310920) was used in flow cytometry on human samples (fig 2a). J Clin Invest (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 2a). elife (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1c
In order to study the differentiation of innate lymphoid cells, BioLegend CD69 antibody (Biolegend, 310930) was used in flow cytometry on human samples (fig 1c). Cell (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig s2
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig s2). Oncoimmunology (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; rhesus macaque; loading ...
In order to examine the kinetics of SIV-specific CD8+ T cell cytolytic factor expression in peripheral blood, lymph node, spleen, and gut mucosa from early acute infection through chronic infection, BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on rhesus macaque samples . PLoS Pathog (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 2b
In order to characterize CD8 positive alpha beta gamma delta T cells, BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 2b). J Immunol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 1e
In order to investigate the role of Eomes in the retention of liver natural killer cells, BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 1e). J Immunol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 8a
In order to characterize CD8 positive T cell subsets in dengue patients from India and Thailand, BioLegend CD69 antibody (Biolegend, 310920) was used in flow cytometry on human samples (fig 8a). J Virol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 5b
BioLegend CD69 antibody (Biolegend, 310910) was used in flow cytometry on human samples (fig 5b). Cell (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig s5
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig s5). PLoS Pathog (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1b
In order to ask if CD2 is involved in the response of adaptive natural killer cells to HCMV, BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; rhesus macaque; tbl 1
In order to characterize the role of T-cell depletion and macrophage polarization and infection during splenic damage during SIV infection, BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on rhesus macaque samples (tbl 1). Am J Pathol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; rhesus macaque; loading ...; fig s3a
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on rhesus macaque samples (fig s3a). J Immunol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig s9
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig s9). Am J Transplant (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 2
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig 2). J Virol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 4
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 4). Int Immunol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 5
BioLegend CD69 antibody (BD Biolegend, FN50) was used in flow cytometry on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3d
In order to examine if pregnancy-related changes in disease activity are associated with changes in T cell populations, BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig 3d). Arthritis Res Ther (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 1
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
In order to optimize detection of IL-2 from live cells, BioLegend CD69 antibody (BioLegend, 310908) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BioLegend CD69 antibody (Biolegend, 310925) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig s3
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig s3). J Immunol (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 7
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig 7). Toxicol Sci (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples . Eur J Immunol (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, BioLegend CD69 antibody (BioLegend, clone FN50) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples . Immunology (2014) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (FN50)
  • flow cytometry; chimpanzee
In order to study the in vitro response of gammadelta T-cell subsets from HIV1-infected and control chimpanzees to T-cell activators, BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on chimpanzee samples . J Med Primatol (2014) ncbi
mouse monoclonal (FN50)
In order to assess the effect of delayed administration of the BCG vaccine on the induced immune response in Ugandan children, BioLegend CD69 antibody (Biolegend, FN50) was used . J Infect Dis (2014) ncbi
Invitrogen
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3a
Invitrogen CD69 antibody (Invitrogen, MA1-10276) was used in flow cytometry on human samples (fig 3a). J Immunother Cancer (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 2a). Cell (2020) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3c
Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 3c). BMC Immunol (2020) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; human; loading ...; fig 1c
Invitrogen CD69 antibody (Thermo Fisher, CH/4) was used in flow cytometry on human samples (fig 1c). Antimicrob Agents Chemother (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 8d
Invitrogen CD69 antibody (ThermoFisher, PA5-84010) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 8d). Front Immunol (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig s3
Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig s3). Nature (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig e4d
Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig e4d). Nature (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 4b). Nature (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 2a
Invitrogen CD69 antibody (eBioscience, FN50) was used in flow cytometry on human samples (fig 2a). Front Immunol (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD69 antibody (Thermo Fisher, FN50) was used in flow cytometry on human samples (fig 1a). BMC Res Notes (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 5a
Invitrogen CD69 antibody (eBioscience, FN50) was used in flow cytometry on human samples (fig 5a). Front Immunol (2019) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; human; 1:200; loading ...; fig 5c
Invitrogen CD69 antibody (Thermo Fisher, MHCD6905) was used in flow cytometry on human samples at 1:200 (fig 5c). elife (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1e
Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 1e). J Clin Invest (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig s3
Invitrogen CD69 antibody (eBioscience, FN50) was used in flow cytometry on human samples (fig s3). Immunol Cell Biol (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3f
Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 3f). J Immunol (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s4e
Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig s4e). J Exp Med (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen CD69 antibody (eBiosciences, H1.2F3) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:6; fig s2c
Invitrogen CD69 antibody (ThermoFisher, H1.2F3) was used in flow cytometry on mouse samples at 1:6 (fig s2c). PLoS Pathog (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s3
Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig s3). Front Immunol (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen CD69 antibody (eBiosciences, H1.2F3) was used in flow cytometry on mouse samples (fig 2a). Cancer Cell (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 5c
Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 5c). Eur J Immunol (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig s6b
In order to investigate the effect of polymicrobial sepsis in skin immune response, Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig s6b). PLoS Pathog (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 3c
In order to examine the localization and function of FHL2 in natural killer cells, Invitrogen CD69 antibody (Affymetrix eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 3c). Front Immunol (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; human; loading ...; fig 2d
In order to observe that the use of chimeric antigen receptor technology is a clinically applicable refinement of regulatory T cell therapy for organ transplantation, Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on human samples (fig 2d). Am J Transplant (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1f
In order to explore how antigen-dependent pathways modulate skin-resident memory T cell generation, Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 1f). J Exp Med (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 4c
In order to find that dendritic cells modulate thymic egress, Invitrogen CD69 antibody (ebioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 4c). J Exp Med (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1g
In order to characterize side population T cells, Invitrogen CD69 antibody (eBiosciences, FN50) was used in flow cytometry on human samples (fig 1g). J Clin Invest (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2a
In order to elucidate the role of Tbet in acute lung injury, Invitrogen CD69 antibody (eBioscience, [1H].2F3) was used in flow cytometry on mouse samples (fig 2a). J Leukoc Biol (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3c
In order to demonstrate that the negative regulation of T cell receptor signaling during natural killer T cell development regulates NKT1 and NKT2 differentiation and survival, Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 3c). J Exp Med (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3a
In order to investigate the role of polypyrimidine tract-binding protein 1 in CD4 T cell activation, Invitrogen CD69 antibody (eBioscience, FN50) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s2c
In order to use knockout mice to determine the role of cereblon in T cells, Invitrogen CD69 antibody (eBiosciences, H1.2F3) was used in flow cytometry on mouse samples (fig s2c). Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3c
In order to propose that the ERK-AP-1 axis is important for translating TCR signal strength into proportional activation of downstream events, Invitrogen CD69 antibody (eBiosciences, H1.2F3) was used in flow cytometry on mouse samples (fig 3c). elife (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; 1:40; fig 3
Invitrogen CD69 antibody (eBioscience, 11-0699) was used in flow cytometry on human samples at 1:40 (fig 3). Nat Commun (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 1
In order to study chronic hepatitis C virus infections and the functional dichotomy of V-delta2 gamma-delta T cells and their role in cytotoxicity and not IFN-gamma production, Invitrogen CD69 antibody (eBioscience, FN50) was used in flow cytometry on human samples (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig s1
In order to characterize the immune responses of children immunized with Plasmodium falciparum apical membrane antigen 1, Invitrogen CD69 antibody (eBioscience, FN50) was used in flow cytometry on human samples (fig s1). Vaccine (2016) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; human; fig 3
In order to develop an HLA-A2-specific chimeric antigen receptor and use it to generate alloantigen-specific human T regulatory cells, Invitrogen CD69 antibody (Caltag, LMHCD6901) was used in flow cytometry on human samples (fig 3). J Clin Invest (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig s2
In order to determine the composition of Orai1 channels found at the endoplasmic reticulum-plasma membrane junction, Invitrogen CD69 antibody (eBioscience, FN50) was used in flow cytometry on human samples (fig s2). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; human; loading ...; fig 3a
In order to generate adenoviral vaccines that express HPV-16 E6 and E7 epitopes alone or fused with p16 and assess immune responses, Invitrogen CD69 antibody (Life technologies, CH/4) was used in flow cytometry on human samples (fig 3a). J Immunol (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:100; fig s6b
In order to suggest that locally synthesized C1q promotes tumor growth, Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples at 1:100 (fig s6b). Nat Commun (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...
In order to elucidate the role of TfR1 in adaptive immunity, Invitrogen CD69 antibody (eBioscience, FN50) was used in flow cytometry on human samples . Nat Genet (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
In order to analyze the control of RNA polymerase II and the epigenetic landscape to transcriptionally reprogram target immune cells by HIV Tat, Invitrogen CD69 antibody (eBioscience, 12-0699) was used in flow cytometry on human samples . elife (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 1
In order to discuss the role of T cells in Rasmussen encephalitis, Invitrogen CD69 antibody (eBioscience, FN50) was used in flow cytometry on human samples (fig 1). J Neuroinflammation (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2E
In order to explore the roles of T and B cells in chronic graft-versus-host disease, Invitrogen CD69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 2E). Ann Hematol (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 1
In order to describe the phenotype and functional potential of metastatic differentiated thyroid cancer-associated PD-1 positive T cells, Invitrogen CD69 antibody (eBioscience, FN50) was used in flow cytometry on human samples (fig 1). Cancer Immunol Res (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
Invitrogen CD69 antibody (e-Bioscience, FN50) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3d,4a
In order to explore the interaction between IL-2 and IL-7 in CD4 T-cell memory generation, Invitrogen CD69 antibody (ebioscience, H12F3) was used in flow cytometry on mouse samples (fig 3d,4a). Nat Commun (2014) ncbi
mouse monoclonal (FN50)
  • flow cytometry; African green monkey; fig 4
Invitrogen CD69 antibody (ebioscience, FN50) was used in flow cytometry on African green monkey samples (fig 4). PLoS Pathog (2014) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; human
In order to investigate the effects of Nucleofection on freshly isolated primary CD4 T cell morphology, intracellular calcium levels, cell surface activation markers, and transcriptional activity, Invitrogen CD69 antibody (Caltag, MHCD6904) was used in flow cytometry on human samples . J Immunol Methods (2014) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
Invitrogen CD69 antibody (eBioscience, FN50) was used in flow cytometry on human samples . Clin Exp Immunol (2014) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; human
In order to study defective cellular immune response to pandemic H1N1 influenza A virus in obese and overweight adult humans, Invitrogen CD69 antibody (Invitrogen, noca) was used in flow cytometry on human samples . Obesity (Silver Spring) (2013) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
In order to assess the modulation of different natural killer cell functions by accessory monocytes and PstS-1, Invitrogen CD69 antibody (Invitrogen, FN50) was used in flow cytometry on human samples . BMC Cancer (2012) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; human; fig 2
In order to describe a protocol to assess human NK cell activation following in vitro stimulation with malaria-infected red blood cells, Invitrogen CD69 antibody (Caltag, MHCD6904) was used in flow cytometry on human samples (fig 2). Methods Mol Biol (2013) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 5
Invitrogen CD69 antibody (eBioscience, FN50) was used in flow cytometry on human samples (fig 5). PLoS Pathog (2012) ncbi
mouse monoclonal (CH/4)
In order to compare CD69 expression on T cells from the intestine, spleen, lymph nodes, and blood of normal and SIV-infected macaques, Invitrogen CD69 antibody (Invitrogen, CH/4) was used . PLoS ONE (2011) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 3
In order to study the contribution of the cellular immune response in maintaining nonpathogenic SIV infection in sooty mangabeys, Invitrogen CD69 antibody (Invitrogen, clone FN50) was used in flow cytometry on human samples (fig 3). J Immunol (2011) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; human; fig 2
In order to identify immunological/virological biomarkers associated with sleep quality in patients with chronic hepatitis C, Invitrogen CD69 antibody (Caltag, MHCD6901) was used in flow cytometry on human samples (fig 2). Scand J Immunol (2011) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; human; fig 7
In order to study the molecular mechanisms that regulate the "recall" NK cell response after rabies vaccination, Invitrogen CD69 antibody (Caltag/Invitrogen, CH/4) was used in flow cytometry on human samples (fig 7). J Immunol (2010) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; human; fig 29.2
In order to describe a protocol to assess activation of human NK cells following in vitro stimulation with malaria-infected red blood cells, Invitrogen CD69 antibody (Caltag, MHCD6904) was used in flow cytometry on human samples (fig 29.2). Methods Mol Biol (2010) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; human; fig 4
In order to identify dasatinib-induced genes in chronic myeloid leukemia cells, Invitrogen CD69 antibody (Caltag/Invitrogen, MHCD6904) was used in flow cytometry on human samples (fig 4). Mol Oncol (2008) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
In order to determine the role of CD59 on human CD4+ T cells, Invitrogen CD69 antibody (eBioscience, FN50) was used in flow cytometry on human samples . J Immunol (2009) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; human; fig 2
In order to examine the frequency, phenotype, and function of T regulatory cells in patients with systemic lupus erythematosus and inactive disease, Invitrogen CD69 antibody (Caltag, CH/4) was used in flow cytometry on human samples (fig 2). Clin Exp Immunol (2008) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; African green monkey; loading ...; tbl 2
In order to determine the contribution of chimpanzee CD3(-) CD8(+) natural killer cells in controlling HIV-1 infection, Invitrogen CD69 antibody (Caltag, CH/4) was used in flow cytometry on African green monkey samples (tbl 2). J Gen Virol (2007) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; rhesus macaque; fig 6E
  • flow cytometry; human; fig 2A
In order to characterize filoviral glycoproteins and study their contribution to infection, Invitrogen CD69 antibody (Caltag, CH/4) was used in flow cytometry on rhesus macaque samples (fig 6E) and in flow cytometry on human samples (fig 2A). FASEB J (2006) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; human; fig 1
In order to test if impaired neonatal CD4 T-cell immunity contributes to the low incidence of acute graft-versus-host disease after allogeneic transplantation of hematopoietic stem cells using cord blood, Invitrogen CD69 antibody (Caltag, CH4) was used in flow cytometry on human samples (fig 1). Biol Blood Marrow Transplant (2006) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; human; fig 4
In order to study the interactions between CD4(+)CD25(+) T cells and human CD8(+) T cells, Invitrogen CD69 antibody (Caltag, CH/4) was used in flow cytometry on human samples (fig 4). Eur J Immunol (2003) ncbi
mouse monoclonal (CH/4)
  • flow cytometry; human
In order to elucidate the role of A2ARs in the regulation of immune response, Invitrogen CD69 antibody (Caltag, CH/4) was used in flow cytometry on human samples . Mol Pharmacol (1999) ncbi
Bio-Rad
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, Bio-Rad CD69 antibody (AbD Serotec, MCA 2806) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (HP-4B3)
  • immunocytochemistry; human
Santa Cruz Biotechnology CD69 antibody (Santa Cruz, HP-4B3) was used in immunocytochemistry on human samples . J Virol (2012) ncbi
Beckman Coulter
mouse monoclonal (TP1.55.3)
  • flow cytometry; human; loading ...; fig s2a
Beckman Coulter CD69 antibody (Beckman Coulter, 6607110) was used in flow cytometry on human samples (fig s2a). Cell Rep Med (2021) ncbi
mouse monoclonal (TP1.55.3)
  • flow cytometry; human; 1:80; loading ...; fig s6
Beckman Coulter CD69 antibody (Beckman Coulter, 6607110) was used in flow cytometry on human samples at 1:80 (fig s6). Science (2019) ncbi
mouse monoclonal (TP1.55.3)
  • flow cytometry; African green monkey; loading ...; fig s4
In order to optimize the dosing regimen of neutralizing anti-HIV-1 antibodies, Beckman Coulter CD69 antibody (Beckman Coulter, TP1.55.3) was used in flow cytometry on African green monkey samples (fig s4). Nature (2017) ncbi
mouse monoclonal (TP1.55.3)
  • flow cytometry; human; loading ...
In order to determine the S. Typhi, S. Paratyphi A, and S. Paratyphi B cross-reactive CD4 positive T cell responses elicited by immunization with Ty21a, Beckman Coulter CD69 antibody (Beckman Coulter, TP1.55.3) was used in flow cytometry on human samples . Clin Immunol (2016) ncbi
mouse monoclonal (TP1.55.3)
  • flow cytometry; human; 1:100; fig 3f
In order to investigate the impact of a cancer-specific MUC1 glycoform, Beckman Coulter CD69 antibody (Beckman Coulter, TP1.55.3) was used in flow cytometry on human samples at 1:100 (fig 3f). Nat Immunol (2016) ncbi
mouse monoclonal (TP1.55.3)
  • flow cytometry; human; loading ...; fig 1c
Beckman Coulter CD69 antibody (Beckman-Coulter, TP1.55.3) was used in flow cytometry on human samples (fig 1c). J Immunol (2016) ncbi
mouse monoclonal (TP1.55.3)
  • flow cytometry; rhesus macaque; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, Beckman Coulter CD69 antibody (Beckman Coulter, 6607110) was used in flow cytometry on rhesus macaque samples . Nat Med (2016) ncbi
mouse monoclonal (TP1.55.3)
  • flow cytometry; rhesus macaque; loading ...
Beckman Coulter CD69 antibody (Beckman Coulter, TP1.55.3) was used in flow cytometry on rhesus macaque samples . PLoS ONE (2016) ncbi
mouse monoclonal (TP1.55.3)
  • flow cytometry; human; fig s2
Beckman Coulter CD69 antibody (Beckman Coulter, TP1.55.3) was used in flow cytometry on human samples (fig s2). J Immunol (2015) ncbi
mouse monoclonal (TP1.55.3)
  • flow cytometry; human
Beckman Coulter CD69 antibody (Beckman Coulter, TP1.55.3) was used in flow cytometry on human samples . Arthritis Rheumatol (2015) ncbi
mouse monoclonal (TP1.55.3)
  • flow cytometry; human
Beckman Coulter CD69 antibody (Beckman Coulter, TP1.55.3) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
BD Biosciences
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD69 antibody (BD, FN50) was used in flow cytometry on human samples (fig 3a). BMC Cancer (2020) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 4d
BD Biosciences CD69 antibody (BD Biosciences, 560737) was used in flow cytometry on human samples (fig 4d). elife (2020) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3b
BD Biosciences CD69 antibody (Becton Dickinson, 562617) was used in flow cytometry on human samples (fig 3b). Cell (2020) ncbi
mouse monoclonal (FN50)
  • flow cytometry; African green monkey; loading ...; fig 5a
BD Biosciences CD69 antibody (BD Pharmingen, 557756) was used in flow cytometry on African green monkey samples (fig 5a). PLoS Pathog (2020) ncbi
mouse monoclonal (L78)
  • flow cytometry; human; loading ...
BD Biosciences CD69 antibody (BD, L78) was used in flow cytometry on human samples . PLoS Pathog (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3f
BD Biosciences CD69 antibody (BD Biosciences, FN50) was used in flow cytometry on human samples (fig 3f). J Immunol (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig s5a, s5b
BD Biosciences CD69 antibody (BD Biosciences, FN50) was used in flow cytometry on human samples (fig s5a, s5b). Brain Pathol (2020) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig s2c
BD Biosciences CD69 antibody (BD, FN50) was used in flow cytometry on human samples (fig s2c). Arthritis Res Ther (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1e
BD Biosciences CD69 antibody (BD, 562617) was used in flow cytometry on human samples (fig 1e). Cell (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3b
BD Biosciences CD69 antibody (BD Biosciences, FN50) was used in flow cytometry on human samples (fig 3b). Arthritis Res Ther (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD69 antibody (BD Pharmingen, FN50) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig s9
BD Biosciences CD69 antibody (BD, FN50) was used in flow cytometry on human samples (fig s9). J Clin Invest (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD69 antibody (BD Pharmingen, FN50) was used in flow cytometry on human samples (fig 1c). Front Immunol (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD69 antibody (BD Biosciences, 555530) was used in flow cytometry on human samples (fig 3a). Oncotarget (2018) ncbi
mouse monoclonal (L78)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD69 antibody (BD bioscience, 340560) was used in flow cytometry on human samples (fig 1b). Sci Rep (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; tbl s1
In order to investigate the effect of Shigella infection on human lymphocytes, BD Biosciences CD69 antibody (BD Pharmingen, 555533) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 7
BD Biosciences CD69 antibody (BD Bioscience, FN50) was used in flow cytometry on human samples (fig 7). J Immunol (2017) ncbi
mouse monoclonal (FN50)
  • other; human; fig s1
In order to investigate the mechanisms of toxicity by the negative allosteric modulators of metabotropic glutamate receptor 5, BD Biosciences CD69 antibody (BD/Pharm, 555529) was used in other on human samples (fig s1). Cell Chem Biol (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 6a
In order to detail MAIT cell responses to various microorganisms and cytokines, BD Biosciences CD69 antibody (BD Biosciences, FN50) was used in flow cytometry on human samples (fig 6a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...
BD Biosciences CD69 antibody (BD Biosciences, FN50) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (L78)
  • flow cytometry; human; tbl 1
In order to compare methods of isolating skin mononuclear phagocytes, BD Biosciences CD69 antibody (Becton Dickinson, L78) was used in flow cytometry on human samples (tbl 1). J Leukoc Biol (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1a
In order to use CD49a expression to define subsets of tissue-resident memory T cells in the skin, BD Biosciences CD69 antibody (BD Bioscience, FN50) was used in flow cytometry on human samples (fig 1a). Immunity (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD69 antibody (BD Pharmingen, FN50) was used in flow cytometry on human samples (fig 1a). JCI Insight (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; rhesus macaque; loading ...
In order to examine the kinetics of SIV-specific CD8+ T cell cytolytic factor expression in peripheral blood, lymph node, spleen, and gut mucosa from early acute infection through chronic infection, BD Biosciences CD69 antibody (BD Bioscience, FN50) was used in flow cytometry on rhesus macaque samples . PLoS Pathog (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3
In order to develop a functional assay to assess the risk of developing acute graft-versus-host disease, BD Biosciences CD69 antibody (BD Biosciences, FN50) was used in flow cytometry on human samples (fig 3). J Immunol Res (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 6c
In order to determine which cells express CD83, BD Biosciences CD69 antibody (BD Biosciences, FN50) was used in flow cytometry on human samples (fig 6c). J Immunol (2016) ncbi
mouse monoclonal (L78)
  • flow cytometry; human; loading ...; tbl 3
BD Biosciences CD69 antibody (BD Pharmingen, L78) was used in flow cytometry on human samples (tbl 3). Brain Behav (2016) ncbi
mouse monoclonal (L78)
  • flow cytometry; rhesus macaque; loading ...; fig s11d
In order to assess the efficacy of targeting alpha4 beta7 integrin to treat SIV, BD Biosciences CD69 antibody (BD, 347823) was used in flow cytometry on rhesus macaque samples (fig s11d). Science (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...
In order to report the O-linked N-acetylglucosamine glycoproteome observed in human T cells, BD Biosciences CD69 antibody (BD Biosciences, 555530) was used in flow cytometry on human samples . J Immunol (2016) ncbi
mouse monoclonal (L78)
  • flow cytometry; human; loading ...; fig 5a
In order to explore signaling pathways regulated by RLTPR in T and B cells, BD Biosciences CD69 antibody (BD, L78) was used in flow cytometry on human samples (fig 5a). J Exp Med (2016) ncbi
mouse monoclonal (L78)
  • flow cytometry; mouse; loading ...; fig s2b
BD Biosciences CD69 antibody (BD Biosciences, L78) was used in flow cytometry on mouse samples (fig s2b). J Immunol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 7
In order to study the functions of WASp knock out natural killer cells, BD Biosciences CD69 antibody (BD Biosciences, 562617) was used in flow cytometry on human samples (fig 7). Sci Rep (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; mouse; loading ...; fig 3a
In order to assess the contribution of interferon-induced transmembrane protein 3 to West Nile virus infection, BD Biosciences CD69 antibody (BD Bioscience, 560711) was used in flow cytometry on mouse samples (fig 3a). J Virol (2016) ncbi
mouse monoclonal (L78)
  • flow cytometry; human; loading ...; fig s4f
BD Biosciences CD69 antibody (BD, L78) was used in flow cytometry on human samples (fig s4f). J Clin Invest (2016) ncbi
mouse monoclonal (L78)
  • flow cytometry; African green monkey; loading ...; fig 2b
In order to discuss the use of flow cytometry to examine common marmosets, BD Biosciences CD69 antibody (BD, L78) was used in flow cytometry on African green monkey samples (fig 2b). J Med Primatol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...
In order to test if the two hematopoietic systems in patients with mixed chimerism remain functional and study immunological differences, BD Biosciences CD69 antibody (BD Biosciences, FN50) was used in flow cytometry on human samples . PLoS ONE (2016) ncbi
mouse monoclonal (FN50)
  • other; human; 500 ug/ml; fig 2
BD Biosciences CD69 antibody (Becton Dickinson, 555529) was used in other on human samples at 500 ug/ml (fig 2). J Extracell Vesicles (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD69 antibody (BD, 555531) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (L78)
  • flow cytometry; human; fig 2
BD Biosciences CD69 antibody (BD, 340560) was used in flow cytometry on human samples (fig 2). Oncoimmunology (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 7a
BD Biosciences CD69 antibody (BD Biosciences, 555530) was used in flow cytometry on human samples (fig 7a). Sci Rep (2016) ncbi
mouse monoclonal (L78)
  • flow cytometry; human; fig 7.45.3
In order to validate a single-cell measurement, simultaneously, for cell surface proteins, messenger RNA, and intracellular proteins, BD Biosciences CD69 antibody (BD Biosciences, 341652) was used in flow cytometry on human samples (fig 7.45.3). Curr Protoc Cytom (2016) ncbi
mouse monoclonal (L78)
  • flow cytometry; human; loading ...; fig 4b
In order to study heat-shock protein 70 in non-small cell lung cancer cells, BD Biosciences CD69 antibody (BD, 340560) was used in flow cytometry on human samples (fig 4b). Front Immunol (2015) ncbi
mouse monoclonal (L78)
  • flow cytometry; human; loading ...; fig s3
BD Biosciences CD69 antibody (BD Biosciences, L78) was used in flow cytometry on human samples (fig s3). Sci Transl Med (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 2
BD Biosciences CD69 antibody (BD Biosciences, 557745) was used in flow cytometry on human samples (fig 2). Retrovirology (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BD Biosciences CD69 antibody (BD Biosciences, FN50) was used in flow cytometry on human samples . Clin Cancer Res (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BD Biosciences CD69 antibody (BD Pharmingen, 555530) was used in flow cytometry on human samples . Am J Reprod Immunol (2015) ncbi
mouse monoclonal (L78)
  • flow cytometry; human; loading ...; fig 3a
In order to discuss how to assess the effects of diverse types of alphaLbeta2 inhibitors using peripheral blood of treated patients, BD Biosciences CD69 antibody (BD Biosciences, L78) was used in flow cytometry on human samples (fig 3a). Br J Pharmacol (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; 1:100; fig 6
BD Biosciences CD69 antibody (BD Bioscience, 555530) was used in flow cytometry on human samples at 1:100 (fig 6). Stem Cells Int (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 3
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BD Biosciences CD69 antibody (BD Biosciences, FN50) was used in flow cytometry on human samples (fig 3). Mucosal Immunol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig s17
BD Biosciences CD69 antibody (BD Biosciences, 5555633) was used in flow cytometry on human samples (fig s17). Nat Chem Biol (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, BD Biosciences CD69 antibody (BD Biosciences, clone FN50) was used in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig s3
  • flow cytometry; African green monkey
BD Biosciences CD69 antibody (BD Biosciences, FN50) was used in flow cytometry on human samples (fig s3) and in flow cytometry on African green monkey samples . J Infect Dis (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 1
BD Biosciences CD69 antibody (BD Biosciences, FN50) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (L78)
  • flow cytometry; human; fig 3
BD Biosciences CD69 antibody (BD Biosciences, L78) was used in flow cytometry on human samples (fig 3). J Autoimmun (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BD Biosciences CD69 antibody (BD Pharmingen, 555530) was used in flow cytometry on human samples . Alcohol (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BD Biosciences CD69 antibody (BD, FN50) was used in flow cytometry on human samples . Eur J Cancer (2015) ncbi
mouse monoclonal (L78)
  • flow cytometry; human; fig 4
BD Biosciences CD69 antibody (BD, L78) was used in flow cytometry on human samples (fig 4). J Infect Dis (2015) ncbi
mouse monoclonal (L78)
  • flow cytometry; human; fig 7
BD Biosciences CD69 antibody (BD Biosciences, L78) was used in flow cytometry on human samples (fig 7). Immunol Cell Biol (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 5
In order to study the immune effects of tadalafil in patients with head and neck squamous cell carcinoma., BD Biosciences CD69 antibody (BD, FN50) was used in flow cytometry on human samples (fig 5). Clin Cancer Res (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 1
BD Biosciences CD69 antibody (BD, FN50) was used in flow cytometry on human samples (fig 1). Eur J Immunol (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
In order to study l immune markers in H1N1pdm2009 virus-infected pregnant women, pregnant women with an influenza-like illness, healthy pregnant women, and healthy non-pregnant women, BD Biosciences CD69 antibody (BD, 555532) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (L78)
  • flow cytometry; human
BD Biosciences CD69 antibody (BD Biosciences, L78) was used in flow cytometry on human samples . Cytotherapy (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BD Biosciences CD69 antibody (BD, FN50) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
mouse monoclonal (L78)
  • flow cytometry; human
BD Biosciences CD69 antibody (BD, L78) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BD Biosciences CD69 antibody (BD Biosciences, FN50) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BD Biosciences CD69 antibody (BD Biosciences, 555531) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BD Biosciences CD69 antibody (BD Biosciences, FN50) was used in flow cytometry on human samples . Am J Transplant (2014) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD69 antibody (BD Biosciences, 557745) was used in flow cytometry on human samples (fig 3a). Oncoimmunology (2014) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
In order to discuss methods to isolate exosomes from human plasma/serum obtained from normal controls or cancer patients, BD Biosciences CD69 antibody (BD Biosciences, 555530) was used in flow cytometry on human samples . J Immunol Methods (2014) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
In order to study NK function in solid tumors, BD Biosciences CD69 antibody (BD Biosciences, FN50) was used in flow cytometry on human samples . Int J Cancer (2014) ncbi
mouse monoclonal (L78)
  • flow cytometry; human; loading ...
In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, BD Biosciences CD69 antibody (BD Bioscience, L78) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BD Biosciences CD69 antibody (BD Biosciences, Fn50) was used in flow cytometry on human samples . Retrovirology (2013) ncbi
Leica Biosystems
monoclonal
  • immunohistochemistry; human; fig 4b
In order to determine the expression and function of HLA-G, HLA-G-regulatory microRNAs and the immune cell infiltration in renal cell carcinoma samples, Leica Biosystems CD69 antibody (Leica, NCL−CD69) was used in immunohistochemistry on human samples (fig 4b). Oncoimmunology (2015) ncbi
Articles Reviewed
  1. Fierle J, Brioschi M, de Tiani M, Wetterwald L, Atsaves V, Abram Saliba J, et al. Soluble trivalent engagers redirect cytolytic T cell activity toward tumor endothelial marker 1. Cell Rep Med. 2021;2:100362 pubmed publisher
  2. Petley E, Koay H, Henderson M, Sek K, Todd K, Keam S, et al. MAIT cells regulate NK cell-mediated tumor immunity. Nat Commun. 2021;12:4746 pubmed publisher
  3. Spiegel J, Patel S, Muffly L, Hossain N, Oak J, Baird J, et al. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat Med. 2021;27:1419-1431 pubmed publisher
  4. Barker K, Etesami N, Shenoy A, Arafa E, Lyon de Ana C, Smith N, et al. Lung-resident memory B cells protect against bacterial pneumonia. J Clin Invest. 2021;131: pubmed publisher
  5. Hawerkamp H, Domdey A, Radau L, Sewerin P, Oláh P, Homey B, et al. Tofacitinib downregulates antiviral immune defence in keratinocytes and reduces T cell activation. Arthritis Res Ther. 2021;23:144 pubmed publisher
  6. Zhou S, Meng F, Du S, Qian H, Ding N, Sha H, et al. Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation. J Immunother Cancer. 2021;9: pubmed publisher
  7. Mandolesi M, Sheward D, Hanke L, Ma J, Pushparaj P, Perez Vidakovics L, et al. SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses. Cell Rep Med. 2021;2:100252 pubmed publisher
  8. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
  9. Szabo P, Dogra P, Gray J, Wells S, Connors T, Weisberg S, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797-814.e6 pubmed publisher
  10. Brouwer P, Brinkkemper M, Maisonnasse P, Dereuddre Bosquet N, Grobben M, Claireaux M, et al. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection. Cell. 2021;184:1188-1200.e19 pubmed publisher
  11. Lund M, Howard C, Thurecht K, Campbell D, Mahler S, Walsh B. A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells. BMC Cancer. 2020;20:1214 pubmed publisher
  12. Neidleman J, Luo X, Frouard J, Xie G, Hsiao F, Ma T, et al. Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir. elife. 2020;9: pubmed publisher
  13. Tseng H, Xiong W, Badeti S, Yang Y, Ma M, Liu T, et al. Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma. Nat Commun. 2020;11:4810 pubmed publisher
  14. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  15. Danzer H, Glaesner J, Baerenwaldt A, Reitinger C, Lux A, Heger L, et al. Human Fcγ-receptor IIb modulates pathogen-specific versus self-reactive antibody responses in lyme arthritis. elife. 2020;9: pubmed publisher
  16. Fischer M, Ruhnau J, Schulze J, Obst D, Floel A, Vogelgesang A. Spermine and spermidine modulate T-cell function in older adults with and without cognitive decline ex vivo. Aging (Albany NY). 2020;12:13716-13739 pubmed publisher
  17. Zhou S, Wu W, Wang Z, Wang Z, Su Q, Li X, et al. RelB regulates the homeostatic proliferation but not the function of Tregs. BMC Immunol. 2020;21:37 pubmed publisher
  18. Sorensen E, Macedo A, Resop R, Howard J, Nell R, Sarabia I, et al. Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing Agents. Antimicrob Agents Chemother. 2020;64: pubmed publisher
  19. Grifoni A, Weiskopf D, Ramirez S, Mateus J, Dan J, Moderbacher C, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181:1489-1501.e15 pubmed publisher
  20. Raehtz K, Barrenas F, Xu C, Busman Sahay K, Valentine A, Law L, et al. African green monkeys avoid SIV disease progression by preventing intestinal dysfunction and maintaining mucosal barrier integrity. PLoS Pathog. 2020;16:e1008333 pubmed publisher
  21. Bell L, Lenhart A, Rosenwald A, Monoranu C, Berberich Siebelt F. Lymphoid Aggregates in the CNS of Progressive Multiple Sclerosis Patients Lack Regulatory T Cells. Front Immunol. 2019;10:3090 pubmed publisher
  22. Jimeno R, Lebrusant Fernandez M, Margreitter C, LUCAS B, Veerapen N, Kelly G, et al. Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells. elife. 2019;8: pubmed publisher
  23. Wei J, Long L, Zheng W, Dhungana Y, Lim S, Guy C, et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature. 2019;576:471-476 pubmed publisher
  24. Hang S, Paik D, Yao L, Kim E, Jamma T, Lu J, et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature. 2019;576:143-148 pubmed publisher
  25. Strickley J, Messerschmidt J, Awad M, Li T, Hasegawa T, Ha D, et al. Immunity to commensal papillomaviruses protects against skin cancer. Nature. 2019;: pubmed publisher
  26. Yukawa M, Jagannathan S, Vallabh S, Kartashov A, Chen X, Weirauch M, et al. AP-1 activity induced by co-stimulation is required for chromatin opening during T cell activation. J Exp Med. 2020;217: pubmed publisher
  27. Majer O, Liu B, Kreuk L, Krogan N, Barton G. UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity. Nature. 2019;575:366-370 pubmed publisher
  28. Sanz Ortega L, Rojas J, Portilla Y, Pérez Yagüe S, Barber D. Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions. Front Immunol. 2019;10:2073 pubmed publisher
  29. Pech M, Fong L, Villalta J, Chan L, Kharbanda S, O Brien J, et al. Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance. elife. 2019;8: pubmed publisher
  30. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed publisher
  31. Crank M, Ruckwardt T, Chen M, Morabito K, Phung E, Costner P, et al. A proof of concept for structure-based vaccine design targeting RSV in humans. Science. 2019;365:505-509 pubmed publisher
  32. Banga R, Rebecchini C, Procopio F, Noto A, Munoz O, Ioannidou K, et al. Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement. PLoS Pathog. 2019;15:e1007918 pubmed publisher
  33. Kim A, Han C, Driver I, Olow A, Sewell A, Zhang Z, et al. LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8+ T Cells. J Immunol. 2019;203:1076-1087 pubmed publisher
  34. Fransen N, Crusius J, Smolders J, Mizee M, Van Eden C, Luchetti S, et al. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. Brain Pathol. 2020;30:106-119 pubmed publisher
  35. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  36. Ahmed R, Omidian Z, Giwa A, Cornwell B, Majety N, Bell D, et al. A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen. Cell. 2019;177:1583-1599.e16 pubmed publisher
  37. Humeniuk P, Geiselhart S, Battin C, Webb T, Steinberger P, Paster W, et al. Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor. Sci Rep. 2019;9:7426 pubmed publisher
  38. Swaims Kohlmeier A, Haddad L, Li Z, Brookmeyer K, Baker J, Widom C, et al. Chronic immune barrier dysregulation among women with a history of violence victimization. JCI Insight. 2019;4: pubmed publisher
  39. Zimmermann M, Rose N, Lindner J, Kim H, Gonçalves A, Callegari I, et al. Antigen Extraction and B Cell Activation Enable Identification of Rare Membrane Antigen Specific Human B Cells. Front Immunol. 2019;10:829 pubmed publisher
  40. Terahara K, Iwabuchi R, Hosokawa M, Nishikawa Y, Takeyama H, Takahashi Y, et al. A CCR5+ memory subset within HIV-1-infected primary resting CD4+ T cells is permissive for replication-competent, latently infected viruses in vitro. BMC Res Notes. 2019;12:242 pubmed publisher
  41. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed publisher
  42. Ye Y, Liu M, Tang L, Du F, Liu Y, Hao P, et al. Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis. Arthritis Res Ther. 2019;21:92 pubmed publisher
  43. Yousefi O, Gunther M, Hörner M, Chalupsky J, Wess M, Brandl S, et al. Optogenetic control shows that kinetic proofreading regulates the activity of the T cell receptor. elife. 2019;8: pubmed publisher
  44. Visekruna A, Hartmann S, Sillke Y, Glauben R, Fischer F, Raifer H, et al. Intestinal development and homeostasis require activation and apoptosis of diet-reactive T cells. J Clin Invest. 2019;129:1972-1983 pubmed publisher
  45. Lichnog C, Klabunde S, Becker E, Fuh F, Tripal P, Atreya R, et al. Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease. Front Pharmacol. 2019;10:39 pubmed publisher
  46. Mayassi T, Ladell K, Gudjonson H, McLaren J, Shaw D, Tran M, et al. Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease. Cell. 2019;176:967-981.e19 pubmed publisher
  47. Banki Z, Krabbendam L, Klaver D, Leng T, Kruis S, Mehta H, et al. Antibody opsonization enhances MAIT cell responsiveness to bacteria via a TNF-dependent mechanism. Immunol Cell Biol. 2019;97:538-551 pubmed publisher
  48. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed publisher
  49. Koppejan H, Jansen D, Hameetman M, Thomas R, Toes R, van Gaalen F. Altered composition and phenotype of mucosal-associated invariant T cells in early untreated rheumatoid arthritis. Arthritis Res Ther. 2019;21:3 pubmed publisher
  50. Bern M, Parikh B, Yang L, Beckman D, Poursine Laurent J, Yokoyama W. Inducible down-regulation of MHC class I results in natural killer cell tolerance. J Exp Med. 2019;216:99-116 pubmed publisher
  51. Hayashi T, Momota M, Kuroda E, Kusakabe T, Kobari S, Makisaka K, et al. DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination. Front Immunol. 2018;9:2619 pubmed publisher
  52. Perciani C, Farah B, Kaul R, Ostrowski M, Mahmud S, Anzala O, et al. Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation. J Clin Invest. 2019;129:875-886 pubmed publisher
  53. Ye W, Chew M, Hou J, Lai F, Leopold S, Loo H, et al. Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway. PLoS Pathog. 2018;14:e1007298 pubmed publisher
  54. Petrelli A, Mijnheer G, Hoytema van Konijnenburg D, van der Wal M, Giovannone B, Mocholí E, et al. PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation. J Clin Invest. 2018;128:4669-4681 pubmed publisher
  55. Cooper G, Ostridge K, Khakoo S, Wilkinson T, Staples K. Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus. Front Immunol. 2018;9:1671 pubmed publisher
  56. Xing S, Shao P, Li F, Zhao X, Seo W, Wheat J, et al. Tle corepressors are differentially partitioned to instruct CD8+ T cell lineage choice and identity. J Exp Med. 2018;215:2211-2226 pubmed publisher
  57. Desimio M, Giuliani E, Ferraro A, Adorno G, Doria M. In Vitro Exposure to Prostratin but Not Bryostatin-1 Improves Natural Killer Cell Functions Including Killing of CD4+ T Cells Harboring Reactivated Human Immunodeficiency Virus. Front Immunol. 2018;9:1514 pubmed publisher
  58. Gu C, Borjabad A, Hadas E, Kelschenbach J, Kim B, Chao W, et al. EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment. PLoS Pathog. 2018;14:e1007061 pubmed publisher
  59. Shi Y, Zhang P, Wang G, Liu X, Sun X, Zhang X, et al. Description of organ-specific phenotype, and functional characteristics of tissue resident lymphocytes from liver transplantation donor and research on immune tolerance mechanism of liver. Oncotarget. 2018;9:15552-15565 pubmed publisher
  60. Watanabe K, Luo Y, Da T, Guedan S, Ruella M, Scholler J, et al. Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses. JCI Insight. 2018;3: pubmed publisher
  61. Safya H, Mellouk A, Legrand J, Le Gall S, Benbijja M, Kanellopoulos Langevin C, et al. Variations in Cellular Responses of Mouse T Cells to Adenosine-5'-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage. Front Immunol. 2018;9:360 pubmed publisher
  62. Cho J, Okuma A, Al Rubaye D, Intisar E, Junghans R, Wong W. Engineering Axl specific CAR and SynNotch receptor for cancer therapy. Sci Rep. 2018;8:3846 pubmed publisher
  63. Cortes J, Ambesi Impiombato A, Couronné L, Quinn S, Kim C, da Silva Almeida A, et al. RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis. Cancer Cell. 2018;33:259-273.e7 pubmed publisher
  64. Turner D, Goldklang M, Cvetkovski F, Paik D, Trischler J, Barahona J, et al. Biased Generation and In Situ Activation of Lung Tissue-Resident Memory CD4 T Cells in the Pathogenesis of Allergic Asthma. J Immunol. 2018;200:1561-1569 pubmed publisher
  65. Warthan M, Washington S, Franzese S, Ramus R, Kim K, York T, et al. The role of endoplasmic reticulum aminopeptidase 2 in modulating immune detection of choriocarcinoma. Biol Reprod. 2018;98:309-322 pubmed publisher
  66. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed publisher
  67. Cowan J, Baik S, McCarthy N, Parnell S, White A, Jenkinson W, et al. Aire controls the recirculation of murine Foxp3+ regulatory T-cells back to the thymus. Eur J Immunol. 2018;48:844-854 pubmed publisher
  68. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed publisher
  69. Herndler Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017;114:E9626-E9634 pubmed publisher
  70. Matos T, O Malley J, Lowry E, Hamm D, Kirsch I, Robins H, et al. Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing ?? T cell clones. J Clin Invest. 2017;127:4031-4041 pubmed publisher
  71. Danahy D, Anthony S, Jensen I, Hartwig S, Shan Q, Xue H, et al. Polymicrobial sepsis impairs bystander recruitment of effector cells to infected skin despite optimal sensing and alarming function of skin resident memory CD8 T cells. PLoS Pathog. 2017;13:e1006569 pubmed publisher
  72. Pinaud L, Samassa F, Porat Z, Ferrari M, Belotserkovsky I, Parsot C, et al. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes. Proc Natl Acad Sci U S A. 2017;114:9954-9959 pubmed publisher
  73. Zhang X, Lian X, Dai Z, Zheng H, Chen X, Zheng Y. ?3-Deletion Isoform of HLA-A11 Modulates Cytotoxicity of NK Cells: Correlations with HIV-1 Infection of Cells. J Immunol. 2017;199:2030-2042 pubmed publisher
  74. Lunemann S, Martrus G, Goebels H, Kautz T, Langeneckert A, Salzberger W, et al. Hobit expression by a subset of human liver-resident CD56bright Natural Killer cells. Sci Rep. 2017;7:6676 pubmed publisher
  75. Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed publisher
  76. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  77. Shah F, Stepan A, O Mahony A, Velichko S, Folias A, Houle C, et al. Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators. Cell Chem Biol. 2017;24:858-869.e5 pubmed publisher
  78. Dulberger C, McMurtrey C, Hölzemer A, Neu K, Liu V, Steinbach A, et al. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017;46:1018-1029.e7 pubmed publisher
  79. Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443 pubmed publisher
  80. Watanabe R, Shirai T, Namkoong H, Zhang H, Berry G, Wallis B, et al. Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity. J Clin Invest. 2017;127:2725-2738 pubmed publisher
  81. Lepore M, Kalinichenko A, Calogero S, Kumar P, Paleja B, Schmaler M, et al. Functionally diverse human T cells recognize non-microbial antigens presented by MR1. elife. 2017;6: pubmed publisher
  82. Descours B, Petitjean G, López Zaragoza J, Bruel T, Raffel R, Psomas C, et al. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature. 2017;543:564-567 pubmed publisher
  83. Nishimura Y, Gautam R, Chun T, Sadjadpour R, Foulds K, Shingai M, et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature. 2017;543:559-563 pubmed publisher
  84. Lim A, Li Y, Lopez Lastra S, Stadhouders R, Paul F, Casrouge A, et al. Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation. Cell. 2017;168:1086-1100.e10 pubmed publisher
  85. Botting R, Bertram K, Baharlou H, Sandgren K, Fletcher J, Rhodes J, et al. Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes. J Leukoc Biol. 2017;101:1393-1403 pubmed publisher
  86. Baranek T, Morello E, Valayer A, Aimar R, Bréa D, Henry C, et al. FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection. Front Immunol. 2017;8:123 pubmed publisher
  87. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang S, Marquardt N, et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017;46:287-300 pubmed publisher
  88. Su S, Zou Z, Chen F, Ding N, Du J, Shao J, et al. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. Oncoimmunology. 2017;6:e1249558 pubmed publisher
  89. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed publisher
  90. Roberts E, Carnathan D, Li H, Shaw G, Silvestri G, Betts M. Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog. 2016;12:e1006135 pubmed publisher
  91. Boardman D, Philippeos C, Fruhwirth G, Ibrahim M, Hannen R, Cooper D, et al. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. Am J Transplant. 2017;17:931-943 pubmed publisher
  92. Sairafi D, Stikvoort A, Gertow J, Mattsson J, Uhlin M. Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. J Immunol Res. 2016;2016:5601204 pubmed
  93. Muschaweckh A, Buchholz V, Fellenzer A, Hessel C, König P, Tao S, et al. Antigen-dependent competition shapes the local repertoire of tissue-resident memory CD8+ T cells. J Exp Med. 2016;213:3075-3086 pubmed
  94. Kadivar M, Petersson J, Svensson L, Marsal J. CD8??+ ?? T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease. J Immunol. 2016;197:4584-4592 pubmed
  95. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  96. Zamora Pineda J, Kumar A, Suh J, Zhang M, Saba J. Dendritic cell sphingosine-1-phosphate lyase regulates thymic egress. J Exp Med. 2016;213:2773-2791 pubmed
  97. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  98. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  99. Byrareddy S, Arthos J, Cicala C, Villinger F, Ortiz K, Little D, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science. 2016;354:197-202 pubmed
  100. Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy R, et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol. 2016;90:11259-11278 pubmed
  101. Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J, et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16 pubmed publisher
  102. Lund P, Elias J, Davis M. Global Analysis of O-GlcNAc Glycoproteins in Activated Human T Cells. J Immunol. 2016;197:3086-3098 pubmed
  103. Roncagalli R, Cucchetti M, Jarmuzynski N, Gregoire C, Bergot E, Audebert S, et al. The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells. J Exp Med. 2016;213:2437-2457 pubmed
  104. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed publisher
  105. Boddupalli C, Nair S, Gray S, Nowyhed H, Verma R, Gibson J, et al. ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells. J Clin Invest. 2016;126:3905-3916 pubmed publisher
  106. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  107. Le Gars M, Haustant M, Klezovich Bénard M, Paget C, Trottein F, Goossens P, et al. Mechanisms of Invariant NKT Cell Activity in Restraining Bacillus anthracis Systemic Dissemination. J Immunol. 2016;197:3225-3232 pubmed
  108. Hoegl S, Ehrentraut H, Brodsky K, Victorino F, Golden Mason L, Eltzschig H, et al. NK cells regulate CXCR2+ neutrophil recruitment during acute lung injury. J Leukoc Biol. 2017;101:471-480 pubmed publisher
  109. Beatson R, Tajadura Ortega V, Achkova D, Picco G, Tsourouktsoglou T, Klausing S, et al. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat Immunol. 2016;17:1273-1281 pubmed publisher
  110. Drennan M, Govindarajan S, Verheugen E, Coquet J, Staal J, McGuire C, et al. NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20. J Exp Med. 2016;213:1973-81 pubmed publisher
  111. La Porta J, Matus Nicodemos R, Valentin Acevedo A, Covey L. The RNA-Binding Protein, Polypyrimidine Tract-Binding Protein 1 (PTBP1) Is a Key Regulator of CD4 T Cell Activation. PLoS ONE. 2016;11:e0158708 pubmed publisher
  112. Hervier B, Perez M, Allenbach Y, Devilliers H, Cohen F, Uzunhan Y, et al. Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome. J Immunol. 2016;197:1621-30 pubmed publisher
  113. Kritikou J, Dahlberg C, Baptista M, Wagner A, Banerjee P, Gwalani L, et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep. 2016;6:30636 pubmed publisher
  114. Rölle A, Halenius A, Ewen E, Cerwenka A, Hengel H, Momburg F. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol. 2016;46:2420-2425 pubmed publisher
  115. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed publisher
  116. Gorman M, Poddar S, Farzan M, Diamond M. The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis. J Virol. 2016;90:8212-25 pubmed publisher
  117. Allison K, Sajti E, Collier J, Gosselin D, Troutman T, Stone E, et al. Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells. elife. 2016;5: pubmed publisher
  118. van Wilgenburg B, Scherwitzl I, Hutchinson E, Leng T, Kurioka A, Kulicke C, et al. MAIT cells are activated during human viral infections. Nat Commun. 2016;7:11653 pubmed publisher
  119. Williams D, Engle E, Shirk E, Queen S, Gama L, Mankowski J, et al. Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection. Am J Pathol. 2016;186:2068-2087 pubmed publisher
  120. Xu Y, Chaudhury A, Zhang M, Savoldo B, Metelitsa L, Rodgers J, et al. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest. 2016;126:2678-88 pubmed publisher
  121. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  122. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed publisher
  123. Yin W, Tong S, Zhang Q, Shao J, Liu Q, Peng H, et al. Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production. Sci Rep. 2016;6:26296 pubmed publisher
  124. Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al. Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?. PLoS ONE. 2016;11:e0154737 pubmed publisher
  125. Graves S, Kouriba B, Diarra I, Daou M, Niangaly A, Coulibaly D, et al. Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate. Vaccine. 2016;34:2546-55 pubmed publisher
  126. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed publisher
  127. Zurawski G, Zurawski S, Flamar A, Richert L, Wagner R, Tomaras G, et al. Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques. PLoS ONE. 2016;11:e0153484 pubmed publisher
  128. Rueda C, Presicce P, Jackson C, Miller L, Kallapur S, Jobe A, et al. Lipopolysaccharide-Induced Chorioamnionitis Promotes IL-1-Dependent Inflammatory FOXP3+ CD4+ T Cells in the Fetal Rhesus Macaque. J Immunol. 2016;196:3706-15 pubmed publisher
  129. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  130. Macdonald K, Hoeppli R, Huang Q, Gillies J, Luciani D, Orban P, et al. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. J Clin Invest. 2016;126:1413-24 pubmed publisher
  131. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  132. Gao J, Duan Z, Zhang L, Huang X, Long L, Tu J, et al. Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. Oncoimmunology. 2016;5:e1048061 pubmed
  133. Woo J, Srikanth S, Nishi M, Ping P, Takeshima H, Gwack Y. Junctophilin-4, a component of the endoplasmic reticulum-plasma membrane junctions, regulates Ca2+ dynamics in T cells. Proc Natl Acad Sci U S A. 2016;113:2762-7 pubmed publisher
  134. Offersen R, Nissen S, Rasmussen T, Østergaard L, Denton P, Søgaard O, et al. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells. J Virol. 2016;90:4441-4453 pubmed publisher
  135. Setoguchi R. IL-15 boosts the function and migration of human terminally differentiated CD8+ T cells by inducing a unique gene signature. Int Immunol. 2016;28:293-305 pubmed publisher
  136. Garcia Bates T, Kim E, Concha Benavente F, Trivedi S, Mailliard R, Gambotto A, et al. Enhanced Cytotoxic CD8 T Cell Priming Using Dendritic Cell-Expressing Human Papillomavirus-16 E6/E7-p16INK4 Fusion Protein with Sequenced Anti-Programmed Death-1. J Immunol. 2016;196:2870-8 pubmed publisher
  137. Muller L, Mitsuhashi M, Simms P, Gooding W, Whiteside T. Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets. Sci Rep. 2016;6:20254 pubmed publisher
  138. Bulla R, Tripodo C, Rami D, Ling G, Agostinis C, Guarnotta C, et al. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation. Nat Commun. 2016;7:10346 pubmed publisher
  139. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed publisher
  140. Tham M, Schlör G, Yerly D, Mueller C, Surbek D, Villiger P, et al. Reduced pro-inflammatory profile of γδT cells in pregnant patients with rheumatoid arthritis. Arthritis Res Ther. 2016;18:26 pubmed publisher
  141. Soh K, Tario J, Colligan S, Maguire O, Pan D, Minderman H, et al. Simultaneous, Single-Cell Measurement of Messenger RNA, Cell Surface Proteins, and Intracellular Proteins. Curr Protoc Cytom. 2016;75:7.45.1-7.45.33 pubmed publisher
  142. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed publisher
  143. Whisenant T, Peralta E, Aarreberg L, Gao N, Head S, Ordoukhanian P, et al. The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells. PLoS ONE. 2015;10:e0144409 pubmed publisher
  144. Günther S, Ostheimer C, Stangl S, Specht H, Mózes P, Jesinghaus M, et al. Correlation of Hsp70 Serum Levels with Gross Tumor Volume and Composition of Lymphocyte Subpopulations in Patients with Squamous Cell and Adeno Non-Small Cell Lung Cancer. Front Immunol. 2015;6:556 pubmed publisher
  145. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed publisher
  146. Reeder J, Kwak Y, McNamara R, Forst C, D Orso I. HIV Tat controls RNA Polymerase II and the epigenetic landscape to transcriptionally reprogram target immune cells. elife. 2015;4: pubmed publisher
  147. Heigele A, Joas S, Regensburger K, Kirchhoff F. Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels. Retrovirology. 2015;12:86 pubmed publisher
  148. Rosario M, Liu B, Kong L, Collins L, Schneider S, Chen X, et al. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas. Clin Cancer Res. 2016;22:596-608 pubmed publisher
  149. Djurisic S, Skibsted L, Hviid T. A Phenotypic Analysis of Regulatory T Cells and Uterine NK Cells from First Trimester Pregnancies and Associations with HLA-G. Am J Reprod Immunol. 2015;74:427-44 pubmed publisher
  150. Welzenbach K, Mancuso R, Krähenbühl S, Weitz Schmidt G. A novel multi-parameter assay to dissect the pharmacological effects of different modes of integrin αLβ2 inhibition in whole blood. Br J Pharmacol. 2015;172:4875-87 pubmed publisher
  151. Owens G, Erickson K, Malone C, Pan C, Huynh M, Chang J, et al. Evidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis. J Neuroinflammation. 2015;12:134 pubmed publisher
  152. Moslem M, Eberle I, Weber I, Henschler R, Cantz T. Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34(pos) Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction. Stem Cells Int. 2015;2015:843058 pubmed publisher
  153. Jasinski Bergner S, Stoehr C, Bukur J, Massa C, Braun J, Hüttelmaier S, et al. Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma. Oncoimmunology. 2015;4:e1008805 pubmed
  154. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  155. Bradshaw J, McFarland J, Paavilainen V, Bisconte A, Tam D, Phan V, et al. Prolonged and tunable residence time using reversible covalent kinase inhibitors. Nat Chem Biol. 2015;11:525-31 pubmed publisher
  156. Shao L, Lie A, Zhang Y, Wong C, Kwong Y. Aberrant germinal center formation, follicular T-helper cells, and germinal center B-cells were involved in chronic graft-versus-host disease. Ann Hematol. 2015;94:1493-504 pubmed publisher
  157. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  158. Deng N, Mosmann T. Optimization of the cytokine secretion assay for human IL-2 in single and combination assays. Cytometry A. 2015;87:777-83 pubmed publisher
  159. Metcalf Pate K, Pohlmeyer C, Walker Sperling V, Foote J, Najarro K, Cryer C, et al. A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads. J Infect Dis. 2015;212:1387-96 pubmed publisher
  160. Rochman Y, Yukawa M, Kartashov A, Barski A. Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig. PLoS ONE. 2015;10:e0122198 pubmed publisher
  161. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed publisher
  162. Tsai C, Liong K, Gunalan M, Li N, Lim D, Fisher D, et al. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus. J Immunol. 2015;194:3890-900 pubmed publisher
  163. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed publisher
  164. Marquardt N, Béziat V, Nyström S, Hengst J, Ivarsson M, Kekäläinen E, et al. Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells. J Immunol. 2015;194:2467-71 pubmed publisher
  165. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  166. Afshar M, Richards S, Mann D, Cross A, Smith G, Netzer G, et al. Acute immunomodulatory effects of binge alcohol ingestion. Alcohol. 2015;49:57-64 pubmed publisher
  167. Phadnis Moghe A, Crawford R, Kaminski N. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6. Toxicol Sci. 2015;144:39-50 pubmed publisher
  168. Hagberg N, Theorell J, Hjorton K, Spee P, Eloranta M, Bryceson Y, et al. Functional anti-CD94/NKG2A and anti-CD94/NKG2C autoantibodies in patients with systemic lupus erythematosus. Arthritis Rheumatol. 2015;67:1000-11 pubmed publisher
  169. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed publisher
  170. Setoguchi R, Matsui Y, Mouri K. mTOR signaling promotes a robust and continuous production of IFN-γ by human memory CD8+ T cells and their proliferation. Eur J Immunol. 2015;45:893-902 pubmed publisher
  171. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
  172. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed publisher
  173. McKinstry K, Strutt T, Bautista B, Zhang W, Kuang Y, Cooper A, et al. Effector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2. Nat Commun. 2014;5:5377 pubmed publisher
  174. Boltjes A, van Montfoort N, Biesta P, Op den Brouw M, Kwekkeboom J, van der Laan L, et al. Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function. J Infect Dis. 2015;211:1268-78 pubmed publisher
  175. Fernandez C, Amarasena T, Kelleher A, Rossjohn J, McCluskey J, Godfrey D, et al. MAIT cells are depleted early but retain functional cytokine expression in HIV infection. Immunol Cell Biol. 2015;93:177-88 pubmed publisher
  176. Trinité B, Chan C, Lee C, Mahajan S, Luo Y, Muesing M, et al. Suppression of Foxo1 activity and down-modulation of CD62L (L-selectin) in HIV-1 infected resting CD4 T cells. PLoS ONE. 2014;9:e110719 pubmed publisher
  177. Weed D, Vella J, Reis I, De La Fuente A, Gomez C, Sargi Z, et al. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2015;21:39-48 pubmed publisher
  178. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed publisher
  179. Cérbulo Vázquez A, Figueroa Damián R, Arriaga Pizano L, Hernández Andrade E, Mancilla Herrera I, Flores Mejía L, et al. Pregnant women infected with pandemic H1N1pdm2009 influenza virus displayed overproduction of peripheral blood CD69+ lymphocytes and increased levels of serum cytokines. PLoS ONE. 2014;9:e107900 pubmed publisher
  180. Alnabhan R, Madrigal A, Saudemont A. Differential activation of cord blood and peripheral blood natural killer cells by cytokines. Cytotherapy. 2015;17:73-85 pubmed publisher
  181. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed publisher
  182. Perreau M, Vigano S, Bellanger F, Pellaton C, Buss G, Comte D, et al. Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders. J Exp Med. 2014;211:2033-45 pubmed publisher
  183. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  184. Bae J, Lee S, Park C, Lee Y, Chun T. Trafficking of LAG-3 to the surface on activated T cells via its cytoplasmic domain and protein kinase C signaling. J Immunol. 2014;193:3101-12 pubmed publisher
  185. Meier D, Docena G, Ramisch D, Toscanini U, Berardi G, Gondolesi G, et al. Immunological status of isolated lymphoid follicles after intestinal transplantation. Am J Transplant. 2014;14:2148-58 pubmed publisher
  186. Compte M, Álvarez Cienfuegos A, Nuñez Prado N, Sainz Pastor N, Blanco Toribio A, Pescador N, et al. Functional comparison of single-chain and two-chain anti-CD3-based bispecific antibodies in gene immunotherapy applications. Oncoimmunology. 2014;3:e28810 pubmed
  187. Booth J, Toapanta F, Salerno Goncalves R, Patil S, Kader H, Safta A, et al. Characterization and functional properties of gastric tissue-resident memory T cells from children, adults, and the elderly. Front Immunol. 2014;5:294 pubmed publisher
  188. Jacquelin B, Petitjean G, Kunkel D, Liovat A, Jochems S, Rogers K, et al. Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection. PLoS Pathog. 2014;10:e1004241 pubmed publisher
  189. Muller L, Hong C, Stolz D, Watkins S, Whiteside T. Isolation of biologically-active exosomes from human plasma. J Immunol Methods. 2014;411:55-65 pubmed publisher
  190. Vogel K, Thomann S, Vogel B, Schuster P, Schmidt B. Both plasmacytoid dendritic cells and monocytes stimulate natural killer cells early during human herpes simplex virus type 1 infections. Immunology. 2014;143:588-600 pubmed publisher
  191. Zhang M, Ma Z, Selliah N, Weiss G, Genin A, Finkel T, et al. The impact of Nucleofection® on the activation state of primary human CD4 T cells. J Immunol Methods. 2014;408:123-31 pubmed publisher
  192. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  193. Hodara V, Parodi L, Chavez D, Smith L, Lanford R, Giavedoni L. Characterization of ??T cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro. J Med Primatol. 2014;43:258-71 pubmed publisher
  194. Prinz P, Mendler A, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int J Cancer. 2014;135:1832-41 pubmed publisher
  195. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  196. Zouk H, d Hennezel E, Du X, Ounissi Benkalha H, Piccirillo C, Polychronakos C. Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locus. Clin Exp Immunol. 2014;175:485-97 pubmed publisher
  197. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed publisher
  198. Lutwama F, Kagina B, Wajja A, Waiswa F, Mansoor N, Kirimunda S, et al. Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants. J Infect Dis. 2014;209:887-97 pubmed publisher
  199. Li H, Pauza C. Critical roles for Akt kinase in controlling HIV envelope-mediated depletion of CD4 T cells. Retrovirology. 2013;10:60 pubmed publisher
  200. Paich H, Sheridan P, Handy J, Karlsson E, Schultz Cherry S, Hudgens M, et al. Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity (Silver Spring). 2013;21:2377-86 pubmed publisher
  201. Gottschalk N, Lang S, Kimmig R, Singh M, Brandau S. Monocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell lines. BMC Cancer. 2012;12:451 pubmed publisher
  202. Horowitz A, Riley E. Activation of human NK cells by Plasmodium-infected red blood cells. Methods Mol Biol. 2013;923:447-64 pubmed
  203. Daigneault M, de Silva T, Bewley M, Preston J, Marriott H, Mitchell A, et al. Monocytes regulate the mechanism of T-cell death by inducing Fas-mediated apoptosis during bacterial infection. PLoS Pathog. 2012;8:e1002814 pubmed publisher
  204. Schroeder N, Chung C, Chen C, Liao C, Chang W. The lipid raft-associated protein CD98 is required for vaccinia virus endocytosis. J Virol. 2012;86:4868-82 pubmed publisher
  205. Wang X, Xu H, Alvarez X, Pahar B, Moroney Rasmussen T, Lackner A, et al. Distinct expression patterns of CD69 in mucosal and systemic lymphoid tissues in primary SIV infection of rhesus macaques. PLoS ONE. 2011;6:e27207 pubmed publisher
  206. Meythaler M, Wang Z, Martinot A, Pryputniewicz S, Kasheta M, McClure H, et al. Early induction of polyfunctional simian immunodeficiency virus (SIV)-specific T lymphocytes and rapid disappearance of SIV from lymph nodes of sooty mangabeys during primary infection. J Immunol. 2011;186:5151-61 pubmed publisher
  207. de Almeida C, de Lima T, Castro D, Torres K, da Silva Braga W, Peruhype Magalhães V, et al. Immunological/virological peripheral blood biomarkers and distinct patterns of sleeping quality in chronic hepatitis C patients. Scand J Immunol. 2011;73:486-95 pubmed publisher
  208. Horowitz A, Behrens R, Okell L, Fooks A, Riley E. NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination. J Immunol. 2010;185:2808-18 pubmed publisher
  209. Horowitz A, Riley E. Activation of human NK cells by malaria-infected red blood cells. Methods Mol Biol. 2010;612:429-46 pubmed publisher
  210. Hantschel O, Gstoettenbauer A, Colinge J, Kaupe I, Bilban M, Burkard T, et al. The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in chronic myeloid leukemia. Mol Oncol. 2008;2:272-81 pubmed publisher
  211. Sivasankar B, Longhi M, Gallagher K, Betts G, Morgan B, Godkin A, et al. CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy?. J Immunol. 2009;182:5203-7 pubmed publisher
  212. Yates J, Whittington A, Mitchell P, Lechler R, Lightstone L, Lombardi G. Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin Exp Immunol. 2008;153:44-55 pubmed publisher
  213. Rodriguez A, Arulanandam B, Hodara V, McClure H, Cobb E, Salas M, et al. Influence of interleukin-15 on CD8+ natural killer cells in human immunodeficiency virus type 1-infected chimpanzees. J Gen Virol. 2007;88:641-51 pubmed publisher
  214. Yaddanapudi K, Palacios G, Towner J, Chen I, Sariol C, Nichol S, et al. Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses. FASEB J. 2006;20:2519-30 pubmed publisher
  215. Chen L, Cohen A, Lewis D. Impaired allogeneic activation and T-helper 1 differentiation of human cord blood naive CD4 T cells. Biol Blood Marrow Transplant. 2006;12:160-71 pubmed
  216. Camara N, Sebille F, Lechler R. Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation. Eur J Immunol. 2003;33:3473-83 pubmed
  217. Koshiba M, Rosin D, Hayashi N, Linden J, Sitkovsky M. Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol Pharmacol. 1999;55:614-24 pubmed